Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Coiled-coil domain containing 90B pseudogene (LOC643014, ENSG00000251017) is a genomic element classified as a pseudogene, meaning it resembles the functional CCDC90B coding gene but has accumulated mutations that prevent it from encoding a functional protein[1][4][5][7][10]. Pseudogenes may be transcribed as RNA and can participate in regulatory processes, such as acting as microRNA decoys or producing interfering RNAs that affect gene expression; however, specific biological roles for this particular pseudogene are uncharacterized. While some pseudogenes have emergent regulatory functions or serve as noncoding RNA sources, the LOC643014 locus is *not* recognized as a therapeutic target, marker, or established participant in disease[2][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coiled-coil domain containing 90B pseudogene (CCDC90B pseudogene).